Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study

First line treatment for Parkinson’s disease (PD) is typically either L-dopa or a non-ergot dopamine agonist (DA). However, the options for the treatment of motor symptoms in PD patients have increased in the last thirty years, which have seen several new classes of PD medications introduced onto th...

Descripción completa

Detalles Bibliográficos
Autores principales: Orayj, Khalid, Akbari, Ashley, Lacey, Arron, Smith, Mathew, Pickrell, Owen, Lane, Emma L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910137/
https://www.ncbi.nlm.nih.gov/pubmed/33679182
http://dx.doi.org/10.1016/j.jsps.2021.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910137/
https://www.ncbi.nlm.nih.gov/pubmed/33679182
http://dx.doi.org/10.1016/j.jsps.2021.01.004

Ejemplares similares